頭孢達肟

化合物

頭孢達肟(其國際非專利藥品名稱為「Cefdaloxime」)是一種第三代頭孢菌素[1][2]

頭孢達肟
臨床資料
ATC碼
  • 未分配
識別資訊
  • (+)-(6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
CAS號80195-36-4  checkY
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard英語CompTox Chemicals Dashboard (EPA)
化學資訊
化學式C14H15N5O6S2
摩爾質量413.434 g/mol
3D模型(JSmol英語JSmol
  • O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=N\O)/c3nc(sc3)N)COC)C(=O)O
  • InChI=1S/C14H15N5O6S2/c1-25-2-5-3-26-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-27-14(15)16-6/h4,8,12,24H,2-3H2,1H3,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1
  • Key:HOGISBSFFHDTRM-GHXIOONMSA-N

參考資料

  1. ^ Sader HS, Runyon BA, Erwin ME, Jones RN. Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis. Diagnostic Microbiology and Infectious Disease. February 1995, 21 (2): 105–10. PMID 7628189. doi:10.1016/0732-8893(94)00148-p. 
  2. ^ Jones, R N; Erwin, M E. Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin. Journal of Clinical Microbiology (American Society for Microbiology). 1992, 30 (5): 1297–1300. ISSN 0095-1137. doi:10.1128/jcm.30.5.1297-1300.1992.